Alpha 2.0
Login Register
» Articles » PMID: 35379666

Why is WHO Pushing Back on a Health Canada-approved Medicago SARS-CoV-2 Vaccine?

Overview
Journal CMAJ
Date 2022 Apr 5
PMID 35379666
Authors
Diana Duong
Lauren Vogel
Affiliations
Soon will be listed here.
Citing Articles

Medicago saga highlights need for WHO clarity on medical R&D involving tobacco.

Houston A Can J Public Health. 2023; 115(1):67-68.

PMID: 38017347 PMC: 10868565. DOI: 10.17269/s41997-023-00839-5.

Recombinant MBP-pσ1 expressed in soybean seeds delays onset and reduces developing disease in an animal model of multiple sclerosis.

Robles L, Reichenberg L, Grissom J, Chi R, Piller K Plant Biotechnol (Tokyo). 2023; 39(4):367-379.

PMID: 37283612 PMC: 10240915. DOI: 10.5511/plantbiotechnology.22.0926a.

Bioprocessing and the Production of Antiviral Biologics in the Prevention and Treatment of Viral Infectious Disease.

Meade E, Rowan N, Garvey M Vaccines (Basel). 2023; 11(5).

PMID: 37243096 PMC: 10223144. DOI: 10.3390/vaccines11050992.

Application of Traditional Vaccine Development Strategies to SARS-CoV-2.

Rando H, Lordan R, Lee A, Naik A, Wellhausen N, Sell E mSystems. 2023; 8(2):e0092722.

PMID: 36861991 PMC: 10134813. DOI: 10.1128/msystems.00927-22.

Current GMP standards for the production of vaccines and antibodies: An overview.

Covarrubias C, Rivera T, Soto C, Deeks T, Kalergis A Front Public Health. 2023; 10:1021905.

PMID: 36743162 PMC: 9891391. DOI: 10.3389/fpubh.2022.1021905.